Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients

Lignende værker

• Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting
  af: Taugner, Julian, et al.
  Udgivet: (2021)
• Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey
  af: Käsmann, Lukas, et al.
  Udgivet: (2020)
• Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis
  af: Karin, Monika, et al.
  Udgivet: (2020)
• Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy
  af: Taugner, Julian, et al.
  Udgivet: (2019)
• Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer
  af: Taugner, Julian, et al.
  Udgivet: (2020)